In contrast, Miao et al., using a transgenic mouse model of vitiligo with T-cell receptor Pmel-1, showed that the PD-L1 fusion protein reduced the number of melanocyte-responsive T cells, inhibited the activation of Vβ12-expressing T cells, and increased the number of Tregs, reversing depigmentation [43]. This evidence concerns the gene CD274 and vitiligo.